Quanterix Corporation Common Stock (QTRX) is a publicly traded Healthcare sector company. As of September 14, 2026, QTRX trades at $2.55 with a market cap of $121.07M and a P/E ratio of -0.98. QTRX moved +0.00% today. Year to date, QTRX is -59.56%; over the trailing twelve months it is -46.56%. Its 52-week range spans $2.15 to $10.28. Analyst consensus is neutral with an average price target of $3.00. Rallies surfaces QTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for QTRX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.55 |
| Market Cap | $121.07M |
| P/E Ratio | -0.98 |
| EPS | $-2.61 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.28 |
| 52-Week Low | $2.15 |
| Volume | 26.19K |
| Avg Volume | 0 |
| Revenue (TTM) | $153.41M |
| Net Income | $-123.11M |
| Gross Margin | 42.69% |
2 analysts cover QTRX: 0 strong buy, 0 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $3.00.